Fulltext

Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country

Chang CT 1 , Lim XJ 2 , Chew CC 3 , Rajan P 2 , Chan HK 4 , Abu Hassan MR 4 Show all authors , Akmal Shafie A 5 , Lee SWH 6

Affiliations 

  • 1 Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health Malaysia, Malaysia; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Selangor, Malaysia
  • 2 Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health Malaysia, Malaysia
  • 3 Clinical Research Centre, Hospital Raja Permaisuri Bainun, Ministry of Health Malaysia, Malaysia; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia
  • 4 Clinical Research Centre, Hospital Sultanah Bahiyah, Ministry of Health Malaysia, Malaysia
  • 5 School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia
  • 6 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500 Selangor, Malaysia; School of Pharmacy, Faculty of Health & Medical Sciences, Taylor's University, Jalan Taylors, Selangor, Malaysia; Center of Global Health, Perelman School of Medicine, University of Pennsylvania, PA, USA. Electronic address: shaun.lee@monash.edu
Vaccine, 2022 Dec 12;40(52):7515-7519.
PMID: 36371369 DOI: 10.1016/j.vaccine.2022.10.057

Abstract

The recent wave of COVID-19 cases has led to the potential need for booster doses. We surveyed 6,294 people and found that 87.6% reported willingness to take a booster dose, with vaccine efficacy rate being the most common reason cited to accept booster dose. Differences in acceptance rates were noted among those working in non-health related sectors, different ethnic groups as well as those who had taken viral vector vaccines.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications